piperazine has been researched along with pyrimidinones in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cagnotto, A; Goegan, M; Mennini, T; Modica, M; Russo, F; Santagati, A; Santagati, M | 1 |
| Bojarski, AJ; Bucki, A; Kazek, G; Kołaczkowski, M; Partyka, A; Pawłowski, M; Satała, G; Siwek, A; Wesołowska, A; Zagórska, A | 1 |
| Babak, MV; Chen, YZ; Cheong, SL; Federico, S; Herr, DR; Klotz, KN; Lim, C; Loo, JSE; Ong, WY; Pastorin, G; Spalluto, G; Tan, A; Venkatesan, G | 1 |
3 other study(ies) available for piperazine and pyrimidinones
| Article | Year |
|---|---|
High potent and selective arylpiperazine derivatives as ligands for the 5-HT1A receptor.
Topics: Animals; Binding Sites; Ligands; Piperazine; Piperazines; Pyrimidinones; Rats; Receptors, Adrenergic, alpha-1; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin; Structure-Activity Relationship; Thiophenes | 2000 |
Structure-activity relationships and molecular studies of novel arylpiperazinylalkyl purine-2,4-diones and purine-2,4,8-triones with antidepressant and anxiolytic-like activity.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Binding Sites; Disease Models, Animal; Models, Molecular; Molecular Structure; Piperazine; Piperazines; Purines; Pyrimidinones; Structure-Activity Relationship | 2015 |
Design, Synthesis and Evaluation of New Indolylpyrimidylpiperazines for Gastrointestinal Cancer Therapy.
Topics: Adenosine A2 Receptor Antagonists; Animals; Cell Proliferation; CHO Cells; Cricetinae; Cricetulus; Gastrointestinal Neoplasms; Humans; Indoles; Models, Molecular; Piperazine; Pyrimidinones; Receptor, Adenosine A2A; Receptor, Adenosine A3; Structure-Activity Relationship | 2019 |